Transcatheter Aortic Valve Replacement Market Size & Share, by Mechanism (Balloon-expanding Valve, Self-expanding Valve); Implantation Procedure; Material; End use - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Transcatheter Aortic Valve Replacement Industry - Regional Synopsis

North America Market Analysis

North America in transcatheter aortic valve replacement market is anticipated to hold over 42.5% revenue share by the end of 2037. The presence of innovation in healthcare infrastructures followed by the existence of a rising aging population, and robust reimbursement facilities are effectively boosting the transcatheter aortic valve replacement market in the region. The January 2024 Population Reference Bureau stated that the elderly population is expected to increase from 58 million in 2022 to 82 million by 2050, and this category’s share of the overall population will rise from 17% to 23%. Therefore, this eventually results in the rising cause of heart disorders which is expected to drive the need for transcatheter aortic valve replacement.

The transcatheter aortic valve replacement market in the US is anticipated to grow over the forecast period. The contributions made by regional organizations combined with approvals from administrative bodies are effectively bolstering the market growth. For instance, in April 2024, Abbott notified that the U.S. Food and Drug Administration (FDA) has approved the organization's first-of-its-kind TriClip transcatheter edge-to-edge repair (TEER) system that's precisely designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve. This follows the recommendation of the Circulatory System Devices Panel of the Medical Devices Advisory Committee for the FDA that the benefits of TriClip overshadowed the risks.

The transcatheter aortic valve replacement market in Canada is witnessing substantial advancement due to the constant involvement of the government towards the objective of adopting healthy lifestyles. Regarding this, a cost-utility analysis was initiated by the Ministry of Health perspective as published in the April 2022 NLM article. The incremental net monetary benefit with the use of probabilistic patient‐level simulation of TAVI care varied from USD 10,765 to USD 17,221. This eventually resulted in a yearly investment of USD 14 million to USD 22 million by the Ontario Ministry of Health to incentivize these performance measures and make them cost‐effective.

Europe Market Statistics

The transcatheter aortic valve replacement market in Europe is the fastest-growing region and is expected to observe worthwhile evolution during the forecast timeline. Factors including rising cardiovascular disorder cases which include the increasing number of TAVR measures, economic expansion, regulatory impacts, and new product launches are responsible for amplifying the market in the region. As per the 2025 WHO report, almost 10,000 people in Europe die due to cardiovascular diseases, resulting in the leading cause of disability. In addition, most of these deaths occur from acute events such as strokes and heart attacks, thereby driving the market demand.

The transcatheter aortic valve replacement market in the UK is poised to expand during the forecast period due to the increasing prevalence of aortic stenosis and government strategies. As per the May 2023 British Heart Foundation Organization article, there has been a rise of 63% in people suffering from cardiac arrest, denoting an increase of 8,000 from 380,787 people. However, to combat this condition, NHS England has taken the initiative to provide rapid ambulance response services for patients requiring the need for cardiac care. For instance, in 2023, the average response time for category 2 calls fell from 40 minutes in March to 29 minutes in April. The authorized target is 18 minutes, but the government has set the latest average target of 30 minutes by 2024, thus driving the market upliftment.

The transcatheter aortic valve replacement market in Germany is projected to grow owing to innovations in technology especially designed to cater to the medical field. According to the December 2023 International Trade Administration report, the medical device market in the country is one of the most profitable healthcare markets internationally, accounting for approximately USD 42 billion yearly or 25% of the Europe market in total. Moreover, 1 out of 6 jobs in Germany are associated with the healthcare industry which generates an economic footprint of USD 883 billion or roughly 12% of Germany’s GDP, thus an optimistic outlook for the market to expand.